📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
5
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for VRSN.
💹 Market Data
Market Cap$27.04B
Shares Outstanding91.00M
Float90.40M
Cash$556.40M
Debt$1.79B
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 3.9% shares (2025Q4 vs prior)
859 institutional holders · 91.47M shares
#1
VANGUARD GROUP INC
11.35M shares
#2
BlackRock, Inc.
9.56M shares
#3
Berkshire Hathaway Inc
8.99M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.10M
Days to Cover2.4
% of Float2.3%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2019
4
INSIDER TRANSACTION
Apr 16, 2026
4
INSIDER TRANSACTION
Apr 15, 2026
4
INSIDER TRANSACTION
Apr 08, 2026
4
INSIDER TRANSACTION
Mar 26, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for VRSN
📊 VRSN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 VRSN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.